Slides and webcasts from ESMO Virtual Plenaries are open to all ESMO Account holders, according to the presenters' agreement to release them.
Login and Watch now!
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Thursday, 16 November 2023 |
Friday, 17 November 2023 |
---|---|
18:30-19:30 CET |
13:00-14:10 CET |
Programme
Welcome and introduction, Scientific background and context Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC Critical analysis and perspectives AACR expert commentary Discussion and Q&A (i) |
Programme
Virtual Plenary Expert Insights: Webcast of 16 November presentations, Discussion and Q&A (ii) Chair Panellists Sanjay Popat, The Royal Marsden Hospital, London, UK Tetsuya Mitsudomi, Kindai University, Osaka, Japan Byoung Chul Cho, Yonsei University, Seoul, Republic of Korea |
Slides and webcasts from ESMO Virtual Plenaries are open to all ESMO Account holders, according to the presenters' agreement to release them.
Login and Watch now!
The ESMO Virtual Plenaries are available to all healthcare professionals working in oncology. You will need a free ESMO Account to watch the presentation. Access to the ESMO Virtual Plenary will be open 30 min before the session starts.
Don't have an ESMO account?
Please set up your ESMO Account now to access the ESMO Virtual Plenary.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.